Credit Suisse’s CRISPR Therapeutics CRSP Stock Holding History

Credit Suisse’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$49M	Sell	719,309 -156,836	-18%	-$10.7M	0.05%	375
2023 Q4	$54.8M	Buy	876,145 +3,214	+0.4%	+$201K	0.05%	356
2023 Q3	$39.6M	Sell	872,931 -48,725	-5%	-$2.21M	0.04%	438
2023 Q2	$51.7M	Buy	921,656 +74,383	+9%	+$4.18M	0.05%	391
2023 Q1	$38.3M	Sell	847,273 -5,616	-0.7%	-$254K	0.04%	464
2022 Q4	$34.7M	Buy	852,889 +12,183	+1%	+$495K	0.04%	500
2022 Q3	$54.9M	Sell	840,706 -82,965	-9%	-$5.42M	0.06%	328
2022 Q2	$56.1M	Sell	923,671 -94,156	-9%	-$5.72M	0.06%	344
2022 Q1	$63.9M	Sell	1,017,827 -75,625	-7%	-$4.75M	0.05%	356
2021 Q4	$82.9M	Buy	1,093,452 +180,911	+20%	+$13.7M	0.04%	310
2021 Q3	$102M	Sell	912,541 -48,573	-5%	-$5.44M	0.06%	258
2021 Q2	$156M	Buy	961,114 +42,404	+5%	+$6.86M	0.08%	187
2021 Q1	$112M	Buy	918,710 +125,266	+16%	+$15.3M	0.06%	273
2020 Q4	$121M	Buy	793,444 +91,158	+13%	+$14M	0.06%	233
2020 Q3	$58.7M	Sell	702,286 -23,624	-3%	-$1.98M	0.04%	384
2020 Q2	$53.3M	Sell	725,910 -125,957	-15%	-$9.26M	0.04%	400
2020 Q1	$36.1M	Buy	851,867 +130,555	+18%	+$5.54M	0.03%	441
2019 Q4	$43.9M	Sell	721,312 -8,516	-1%	-$519K	0.03%	464
2019 Q3	$29.9M	Sell	729,828 -68,644	-9%	-$2.81M	0.03%	532
2019 Q2	$37.6M	Sell	798,472 -92,092	-10%	-$4.34M	0.03%	443
2019 Q1	$31.8M	Buy	890,564 +115,691	+15%	+$4.13M	0.03%	474
2018 Q4	$22.1M	Buy	774,873 +178,821	+30%	+$5.11M	0.02%	609
2018 Q3	$26.4M	Buy	596,052 +213,988	+56%	+$9.49M	0.02%	610
2018 Q2	$22.5M	Sell	382,064 -64,984	-15%	-$3.82M	0.02%	652
2018 Q1	$20.4M	Buy	447,048 +4,203	+0.9%	+$192K	0.02%	716
2017 Q4	$10.4M	Buy	442,845 +362,797	+453%	+$8.52M	0.01%	1018
2017 Q3	$1.43M	Buy	80,048 +48	+0.1%	+$858	﹤0.01%	2400
2017 Q2	$1.28M	Hold	80,000	–	–	﹤0.01%	2191
2017 Q1	$1.74M	Buy	+80,000	New	+$1.74M	﹤0.01%	2128